Professor Mark Wainberg is one of five Canadians honoured for their 2012 CIHR-CMAJ Top Canadian Achievements in Health Research, sponsored by the Canadian Institutes of Health Research (CIHR) and the Canadian Medical Association Journal (CMAJ). The top two achievements, by Professor Mark Wainberg and Professor Darren Warburton, will be published in full in the CMAJ; all five top achievements are highlighted on the CMAJ and CIHR websites. Professor Wainberg was cited for his research on antiviral drug resistance and his work leading to the discovery of Lamivudine (3TC). Lamivudine is one of the world’s most widely used drugs in the treatment of HIV.

Launched in 2008, the awards highlight achievements that have had a substantial impact on health, health care and health research “by improving our understanding of health and human diseases, tackling health challenges, and improving our health system.” The awards honour research in 4 areas: biomedical; clinical; health services; and social, cultural, environmental and population health.

The special report in the CMAJ can be found here